Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoran Rankovic

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitorsJiaqiang Cai, Mark Baugh, Darcey Black, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERGZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
Bioorganic & Medicinal Chemistry|December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsLeonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Nature Communications|January 16, 2024
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonistAngus R Brown, Michael Bosies, Helen Cameron, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitorsJiaqiang Cai, Mark Baugh, Darcey Black, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERGZoran Rankovic, Jiaqiang Cai, Jennifer Kerr, et al.
Bioorganic & Medicinal Chemistry|December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsLeonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Nature Communications|January 16, 2024
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonistAngus R Brown, Michael Bosies, Helen Cameron, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Pageof 7